Insight
Cutting through the noise in femtech – key takeaways from Women’s Health Week 2025

The flagship women’s health summit brought together over 400 visionary founders, funders and innovators, with a shared mission of transforming women’s health worldwide.
This year’s Women’s Health Week, which took place at the Barbican, London from 14-17 October, showcased a sector once considered by funders to be too much of a ‘niche’, meeting a crucial unmet need with huge market demand.
Investments are outperforming their value, regulators want to speed up the route to market, and clinical validation is cutting through the noise and demonstrating real results.
There is a buzz about the femtech sector – or at least there was in the Barbican last week – but experts have urged founders should move forward responsibility, building ethics and equity into their innovations.
Here’s our takeaways from the key conversations at Women’s Health Week.
1. Women’s health is outperforming – but angels and influencers are crucial for raising capital
Investment in women’s health is outperforming, and this trend is expected to continue, according to the panel at Women’s Health Week on Thursday 16th, where fund managers and founders highlighted significant returns, growing institutional interest, and the critical role of early-stage backers.
Sanji Chotai, a senior investment manager at British Business Bank, says she is seeing “really encouraging data” and anticipates more “outperformance”, particularly in medtech, which is drawing interest thanks to “shorter timelines to regulatory approval” and rapid commercialisation.
Series A and B activity is also picking up, but the panel agreed that early-stage capital and angel investors remain essential.
“My first angel investment in a women’s health company, I think on Series A, is going to be 20x on multiple and for our fund, it’s going to be around 9x,” said Trin Linamagi, founding partner at Sie Ventures.
“We need to take bigger bets and double down – and actually put the capital behind these businesses early on.”
Having driven successful campaigns for Soulcycle and Barry’s Bootcamp, Tatum Getty, now a founding general partner at THENA, also highlighted the importance of influencers – and not just on Instagram.
“Who is that person who believes in what we’re building and will tell their friends,” she said.
“Women have not been traditional investors they are more risk averse, smaller investment but bigger impact. They add so much more value than the amount of capital that they contribute.”
2. NICE and new pathways for health technologies
During a discussion on mastering Europe’s regulatory process, a representative from the National Institute for Health and Care Excellence (NICE) outlined how new rules-based approval routes, now being introduced for health technologies, are designed to speed access to innovation.
The body is also better aligning processes with the Medicines and Healthcare products Regulatory Agency (MHRA) to reduce the time it takes to regulatory approval.
“We’re taking forward the rules-based pathway for health tech,” said Kendall Gilmore, a senior advisor at NICE.
“Developing a model more similar to the medicines pathway, where, for some products, it goes through the MHRA, through NICE and then comes with a recommendation that has a funding mandate attached.”
The pathway, currently being developed will see health technologies assessed in a similar way to medicines with the first products approved from April next year.
NICE currently evaluates only a fraction of the 500,000 technologies used daily in the NHS. While a NICE recommendation is “not mandatory”, it can be a “powerful signal” to the NHS.
NICE is constantly “horizon scanning” for “disruptive products” further down the pipeline and is engaging more directly with innovators, industry associations and international partners to identify promising technologies earlier, and a new early value assessment route is giving promising products a faster track.
“If it meets an unmet need, it should be used with further evidence generation,” Gilmore explained.
“This is particularly relevant for digital health and diagnostics.”
3. Scientific validation is the most effective way to ‘cut through the noise’
In a panel exploring how to “cut through the noise” in femtech, founders were urged to bake credibility into product design from day one, with scientific proof and clinical validation the sharpest differentiator, according to Soun Rakshit, of MV Health.
“You have to spend probably two years going through the R&D process,” said Rakshit.
“That is the best and probably the only way to do it, so that by the time you get regulatory approval, you have already had significant patient feedback and iteration.”
Earning trust also means collaborating with experts who understand the problem, as Helen O’Neil, founder of Hertility, explained.
When in the development stage, O’Neil reached out to professionals, including obstetricians and gynaecologists to understand the right questions to ask based on their “clinical intuition and personal experience”.
Rakshit added: “If we can show true clinical evidence, and it does take time, it is the best way to cut through the noise.”

4. Bias in AI is ‘real and harmful’ – and founders need to know how to address it
Experts discussed the role of AI and its potential to both help and harm women’s health, urging proactive testing and human oversight to avoid the risk of decades of a “male default model” being implemented into new solutions.
“AI that’s trained on that skewed data can really fail women,” said Sarah Montgomery Taylor, clinical lead of GenAI evaluation and scaled services at Google, highlighting familiar examples such as heart-attack presentation.
“Biases are real, and they are really harmful, and so being aware of them is so crucial.”
Panellists also flagged “measurement bias” and the “historical dismissal of women’s pain,” where systems trained on those records “can learn to deprioritise” certain signals.
Beyond bias in diagnostics, Marinos Ionnides, head of software and AI medical devices regulation at the MHRA, highlighted the risks of implementing AI in areas where there may be hidden bias.
“I’m quite worried about the deployment of software AI in places where we aren’t we didn’t know we would be finding bias [such as] appointment booking,” he said, adding that in these “unknown unknowns,” “the regulator has their greatest role”.
Founders were urged to be responsible when scaling AI, introducing guardrails such as building in equity and collecting data from the very beginning for “rigorous real-world validation”.
Clinicians need to be able to test the product and understand it to build trust, while regulatory processes should be “adaptive”, offering “clarity on what the path is to market”.
Chen Davies, founder at Anya, shared a real-world example of how products and content tailored for underserved groups drove measurable change, including a “10% population-wise” rise in breastfeeding rates in a deprived area of Blackpool after six months.
“AI should gradually complement human support without replacing it,” said Davies.
5. Consumer data can play a critical role in building the clinical evidence-base
During the final panel, participants argued that continuous real-world data, paired with clinical benchmarks, is the fastest way to fix women’s health’s “male baseline” problem and turn lived experience into evidence.
Dr Chris Curry, clinical director for women’s health at Oura, argued that wearables are “one of the big unlocks” by collecting data that gives the “whole picture of the human”.
But tracking can – should – meet clinical standards, with the panel pushing for globally representative consumer datasets.
“I see consumer data if it’s truly representative, if it’s truly globally representative, being critical,” said Micah Gellman, a senior strategist for women’s health innovation at the Gates Foundation.
“It helps us calibrate and link consumer insights and lived experience to clinical anchors and value outcomes… this kind of consumer data is one avenue that we have to really change investor appetite.”
Rhiannon White, CEO of Clue, which has a long-running research collaboration with Oura, including collecting symptom tracking data on perimenopause and pain, added that women’s spending power can actually steer where future R&D should be focused.
“We are able to shape and direct where people will put their research and put their development with our spending power,” she said.
6. The crisis in government support can be an opportunity for more innovative funding pathways
With the Gates Foundation recently committing an additional US$2.5bn for research in women’s health, Gellman also reframed the reduction in government funding for women’s health – such as that seen under the Trump administration in the US – as an opportunity for more innovate financing.
“There is a real opportunity for European and Asian government funding to step up and fill some of those gaps,” said Gellman.
“An opportunity for government funding and philanthropic funding to take new forms and to be partnering in new ways to catalyse innovation and to work with academics and industry players.”
Rather than a binary between grants and VC, the panel highlighted “blended financing mechanisms, venture philanthropy… different kinds of outcome-based financing” with public and philanthropic dollars used “to de risk, early-stage investment”.
Gellman added: “This crisis that we’re in, in terms of government funding is also an opportunity for innovative financing.”
The comments brought the conference full circle, reminiscent of those made earlier in the day, by Tatum Getty, who highlighted: “Women and small amounts of capital, can make a big difference.”
News
What “women’s healthmaxxing” means for patient trust and the femtech industry

Women’s health has become one of the most searched and shared topics online, from cycle syncing and cortisol management to menopause hacks, supplements, hormone testing and clinician-creator content.
That surge in attention, sometimes dubbed “healthmaxxing,” is changing how women find, evaluate and act on health information, and it is starting to reshape the relationship between patients, clinicians and the companies building products for this market.
For providers, the shift means patients are arriving better informed but also more exposed to unverified claims, putting pressure on clinicians to engage with online narratives rather than dismiss them.
For femtech and pharma companies, it opens a route to reach and educate consumers at scale, but also raises the stakes on credibility: products and messaging that ride the trend without clinical grounding risk eroding the trust the industry has spent years building.
Investors are watching the same dynamic from a different angle.
Attention-driven demand can be a signal of where the next wave of femtech growth will come from, but distinguishing genuine clinical need from viral momentum is increasingly part of due diligence.
The net effect is a widening gap between companies that treat cultural attention as a distribution channel for credible, evidence-based care, and those that risk being swept up in trends with little clinical substance behind them.
How that gap plays out will shape patient trust, clinical relationships and commercial opportunity across the women’s health industry for years to come.
These themes will be explored in more depth in an upcoming webinar, “Women’s Healthmaxxing: The Opportunity & Risks of Cultural Attention for the Women’s Health Industry,” hosted by the Women’s Health Innovation Summit (WHIS), featuring Ellen Wilcox (Listen Ventures), Jessica Bell van der Wal (Frame Fertility), Dr. Tosin Sotubo-Ajayi (NHS, BBC and more) and Nora Lansen (Elektra Health).
Register free for the webinar on 23 July 2026 at https://events.virtualpro.com/womens-health-series-webinar-july-2026/registration
Insight
Rising number of young midwives quitting NHS due to burnout

More young midwives are leaving the NHS before 35 as burnout adds pressure to stretched maternity services, new research has revealed.
The trend has raised concerns about the quality and safety of care for mothers and babies in understaffed maternity units.
During 2025-26, 1,669 midwives aged 34 or under left the health service in England, representing 57 per cent of the 2,949 midwives of all ages who resigned.
The pressures of maternity care, including increasingly complex childbirth and the risks involved, are thought to be among the factors behind the trend.
Hannah Leonard, deputy chief midwife at the Royal College of Midwives, said the exodus of midwives under 35 was “deeply worrying” and showed that too many were ending up “burnt-out within a few years of qualifying because every shift means too few colleagues, missed breaks and unpaid hours”.
She added: “Losing these midwives, and students, even before they qualify, is a terrible waste of talent.”
The figures, revealed in parliamentary questions tabled by the Liberal Democrats, show that 205 of last year’s younger leavers were under 25, while 655 were aged 25 to 29 and 809 were aged 30 to 34.
The number of midwives under 35 leaving the NHS has risen sharply in recent years. The 2025-26 figure was 59 per cent higher than the 1,051 who left in 2014-15, according to NHS figures.
Burnout means long-term physical and emotional exhaustion, often linked to sustained pressure at work.
Separate figures obtained by the Liberal Democrats suggest almost one in four midwifery students are leaving before completing their three-year degree.
In 2021, 3,565 students started a midwifery degree, but 2,725 graduated in 2024, meaning 840, or 24 per cent, did not complete the course.
Midwifery students spend much of their second and third years learning on the job in maternity units.
The loss of staff and students underlines what the Royal College of Midwives has described as a “staffing emergency” in maternity care across the UK.
A recent survey by the Royal College of Midwives found that three-quarters of midwives had considered leaving the profession over the last year, mainly because of concerns over staffing levels and patient safety.
Both recent large-scale reviews of maternity care in England, led by Donna Ockenden and Valerie Amos, identified staffing shortages as a key problem affecting patient safety.
Helen Morgan, the Liberal Democrat health spokesperson, said: “These statistics reveal an alarming crisis in maternity, with far too many midwives burning out early in their career and in their training. Patients are paying the price, and mothers are left with no alternative but to give birth on understaffed and unsafe wards.
“Rather than throw money at yet more new recruits who quit under intolerable pressure, the government needs a new approach. Through guaranteeing protected, year-round training and professional development we can help midwives cope with rising complexity and risk.”
About 10 per cent of all midwives leave the NHS each year.
However, the figures show higher leaving rates among younger midwives, with one in seven, or 14.6 per cent, of those aged 25 to 29 and one in six, or 16.6 per cent, of those aged 30 to 34 leaving during 2025-26.
A Department of Health and Social Care spokesperson said: “Under this government we have a record number of midwives in the workforce and we value the vital service they provide in maternity and neonatal units across the country.
“To make the NHS the best employer it can be, we have introduced new NHS staff standards to improve health and wellbeing support, promote flexible working, as well as crucial measures to tackle violence, sexual harassment or abuse and racism.
“Alongside consecutive above-inflation pay rises, we’ve bolstered the midwifery workforce through our graduate guarantee and recently opened up 1,000 more midwifery roles backed by £10m to help prevent student midwives leaving the profession.”
Department of Health and Social Care figures show a record 25,500 full-time-equivalent midwives are working in the NHS, 2,000 more than when the Labour government took office in July 2024.
Insight
Black women want more accessible breast cancer screening info, study finds

Black women in the UK want clearer, more accessible breast cancer screening information, research has found.
The study looked at why Black African and Black Caribbean women are less likely than white women to attend breast screening.
Researchers at the University of Surrey held focus groups and interviews with 47 Black African and Black Caribbean women aged 50 to 71.
Women in this age group are routinely invited for NHS breast screening.
The researchers said only 45 per cent of Black women attend screening, compared with 63 per cent of white women.
Anietie Aliu, lead author, postgraduate researcher at the University of Surrey and registered nurse, said: “Diagnosing breast cancer early can dramatically improve a person’s chance of survival.
“Breast cancer screening plays an important role in this by identifying the cancer and ensuring a person receives speedy treatment.
“Despite the importance of screening, Black women are less likely to attend appointments than white females.
“This puts them at risk of a potential cancer being diagnosed late and spreading to other areas of the body. We need to understand what is preventing Black women from attending these appointments and help identify ways to remove such barriers.”
The study found a need to increase awareness of breast cancer screening, especially among women less familiar with the service.
Some women, particularly those born outside the UK, knew little about breast screening before receiving their first invitation.
Others questioned why they needed screening when they had no symptoms.
The importance of trusted conversations was also identified.
Researchers found that some Black women expected their GPs to speak to them about breast screening, particularly before they reached screening age.
Although NHS breast screening is organised through national screening services, researchers said GPs often have established relationships with patients and may be well placed to offer brief advice on preventive care, including breast screening.
Participants called for stronger links between GP practices, breast screening services and Black community champions.
They said this could help women receive trusted information, ask questions and feel reassured.
Faith and religious beliefs also shaped decisions for some women.
Some Black African Christian women said illness, including cancer, was not permitted by God in their bodies, while others saw screening as a personal choice that did not conflict with Christian faith.
Muslim women highlighted the importance of being able to state their religion on medical appointment forms to help ensure they were seen by a female mammographer.
A mammographer is a healthcare professional trained to carry out breast screening scans.
Aliu added: “Breast screening can save lives, but our findings show that attendance is shaped by multiple factors, not just awareness, although awareness remains important.
“Women need relatable screening information, reassurance, flexible appointments and services that are accessible within their communities.
“Many felt that invitation letters were too formal, and that leaflets and media imagery did not reflect them, making it harder to relate to screening.”
Dr Afrodita Marcu, senior research fellow at the University of Surrey and member of the research team, said: “We need a more collaborative approach, where primary care, screening services and community voices work together to support women before, during and after the invitation.”
The researchers said future breast screening interventions should be designed with Black women, rather than for them.
They said user-friendly and culturally relevant resources, developed with communities, healthcare professionals and screening services, could improve understanding, reduce fear and make breast screening feel more accessible and reassuring.
Dr Robert Kerrison, associate professor of cancer care at the University of Surrey, said: “There is no question that breast screening can be lifesaving, but we need to make it easier for women to understand, access and feel reassured by the programme.
“This means improving communication, addressing practical barriers and making sure healthcare professionals and community partners are supported to provide clear and trusted information.”
The team has also explored healthcare professionals’ perspectives and worked with stakeholders to develop user-friendly materials with Black women.
Researchers said this co-designed approach could help ensure breast screening messages are culturally relevant, practical and shaped by the people they are intended to support.
Diagnosis2 weeks agoTwo “gamechanger” tests set to speed up endometriosis diagnosis on the NHS
Insight2 weeks agoWomen with PMOS should have annual NHS checks, new guidance says
News5 days agoNew menopause drug approved for use by NHS in Scotland
Cancer2 weeks agoThousands of women could avoid painful cancer exam with new AI blood test
Entrepreneur2 weeks agoApplications open for the third W Accelerate with Merck KGaA and M Ventures
Fertility2 weeks agoOlder women face lower chance of fertility treatment working, even with donor eggs, study finds
News2 weeks agoWe built Ema like a nurse: Here’s why that matters
Wellness2 weeks agoExperts call for regulation of toxic period product chemicals















3 Comments